IDH1 and central nervous system cancer: Subsequently, we explored whether the prognostic value of the seven-gene signature could be extended to IDH-mutant GBM and lower grade glioma (LGG, WHO grade II-III), by calculating a risk score using the same formula in the CGGA and TCGA cohorts.